Physician profile
Alexander Berger
NPI 1215370879
$13,822.03
in general payments reported to CMS, 2019-2025
12 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.34 · 2021: $13.28 · 2022: $2,367 · 2023: $10K · 2024: $673 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,600 · Food and Beverage: $1,795 · Gift: $30.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,600.00 |
| Food and Beverage | $1,795.38 |
| Gift | $30.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $12,786.07 | 2022-2025 | Desara |
| Coloplast Corp | $326.45 | 2022-2025 | Altis, Speedicath |
| Axonics, INC. | $242.69 | 2022-2023 | Bulkamid, Axonics |
| Abbvie INC. | $155.12 | 2022-2025 | Botox |
| Medtronic, INC. | $102.31 | 2023-2025 | Interstim |
| Boston Scientific Corporation | $85.39 | 2023-2025 | Bulkamid, Capio Rp |
| Dentsply Ih Ab | $39.86 | 2023 | Lofric |
| Femselect INC. | $25.00 | 2024 | Enplace |
| Vertex Pharmaceuticals Incorporated | $17.78 | 2025 | |
| Medtronic USA, INC. | $15.34 | 2019 | |
| Astellas Pharma US INC | $13.28 | 2021 | |
| Urovant Sciences INC | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.